165 related articles for article (PubMed ID: 36402443)
1. DICER1 Mutation in Recurrent Ovarian Sertoli-Leydig Cell Tumor: A Case Report.
Liu S; Pokoradi AJ; Soboleski D; Childs T; Agrawal A
J Pediatr Adolesc Gynecol; 2023 Apr; 36(2):107-111. PubMed ID: 36402443
[TBL] [Abstract][Full Text] [Related]
2. DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry.
Schultz KAP; Harris AK; Finch M; Dehner LP; Brown JB; Gershenson DM; Young RH; Field A; Yu W; Turner J; Cost NG; Schneider DT; Stewart DR; Frazier AL; Messinger Y; Hill DA
Gynecol Oncol; 2017 Dec; 147(3):521-527. PubMed ID: 29037807
[TBL] [Abstract][Full Text] [Related]
3. DICER1 -Altered Extraovarian Moderately Differentiated Sertoli-Leydig Cell Tumor: Report of a Rare Case.
Lau JCC; McCluggage WG; Yuen LYP; Shing MMK; Chan GCF; Yam FSD; Leung MWY; Ng WF; Liu APY
Int J Gynecol Pathol; 2023 Jul; 42(4):421-425. PubMed ID: 36044308
[TBL] [Abstract][Full Text] [Related]
4. A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumors.
Conlon N; Schultheis AM; Piscuoglio S; Silva A; Guerra E; Tornos C; Reuter VE; Soslow RA; Young RH; Oliva E; Weigelt B
Mod Pathol; 2015 Dec; 28(12):1603-12. PubMed ID: 26428316
[TBL] [Abstract][Full Text] [Related]
5. A family with Sertoli-Leydig cell tumour, multinodular goiter, and
Haley M; Bindal P; McAuliffe A; Vredenburgh J
Curr Oncol; 2019 Jun; 26(3):183-185. PubMed ID: 31285663
[TBL] [Abstract][Full Text] [Related]
6. Ovarian sex cord-stromal tumors, pleuropulmonary blastoma and DICER1 mutations: a report from the International Pleuropulmonary Blastoma Registry.
Schultz KA; Pacheco MC; Yang J; Williams GM; Messinger Y; Hill DA; Dehner LP; Priest JR
Gynecol Oncol; 2011 Aug; 122(2):246-50. PubMed ID: 21501861
[TBL] [Abstract][Full Text] [Related]
7. Testicular Neoplasms With Sex Cord and Stromal Components Harbor a Recurrent Pattern of Chromosomal Gains.
Acosta AM; Sholl LM; Maclean F; Kao CS; Ulbright TM
Mod Pathol; 2024 Jan; 37(1):100368. PubMed ID: 37871653
[TBL] [Abstract][Full Text] [Related]
8. Bilateral Ovarian Sertoli-Leydig Cell Tumors Harboring
Hughes CE; Liang J; Paulson V; Wang H
Fetal Pediatr Pathol; 2023 Jun; 42(3):472-478. PubMed ID: 36121434
[No Abstract] [Full Text] [Related]
9. Sertoli-Leydig cell tumor in two siblings with DICER1 syndrome: A case report and literature review.
Zhang Y; Ren M; Hong Y; Zhong Y; Cong X; Chen C; Liu Z; Man Y; Yang L
Medicine (Baltimore); 2020 Jul; 99(27):e20806. PubMed ID: 32629665
[TBL] [Abstract][Full Text] [Related]
10. Lessons from genomic profiling: towards a molecular-based classification of ovarian Sertoli-Leydig cell tumour.
Kommoss FKF
Histopathology; 2024 Mar; 84(4):712-714. PubMed ID: 38114269
[TBL] [Abstract][Full Text] [Related]
11. Gynecologic Manifestations of the DICER1 Syndrome.
Stewart CJ; Charles A; Foulkes WD
Surg Pathol Clin; 2016 Jun; 9(2):227-41. PubMed ID: 27241106
[TBL] [Abstract][Full Text] [Related]
12. Sertoli-Leydig cell tumor: a clinicopathological analysis in a comprehensive, national cohort.
Bekker P; Miland-Samuelsen AR; Smerdel MP; Schnack TH; Lauszus FF; Karstensen SH
Int J Gynecol Cancer; 2023 Dec; 33(12):1921-1927. PubMed ID: 37907261
[TBL] [Abstract][Full Text] [Related]
13. The role of FOXL2, SOX9, and β-catenin expression and DICER1 mutation in differentiating sex cord tumor with annular tubules from other sex cord tumors of the ovary.
Onder S; Hurdogan O; Bayram A; Yilmaz I; Sozen H; Yavuz E
Virchows Arch; 2021 Aug; 479(2):317-324. PubMed ID: 33566167
[TBL] [Abstract][Full Text] [Related]
14. Distinct somatic DICER1 hotspot mutations in three metachronous ovarian Sertoli-Leydig cell tumors in a patient with DICER1 syndrome.
Garcia A; Desrosiers L; Scollon S; Gruner S; Reuther J; Gandhi I; Patil N; Fuller MY; Dai H; Muzny D; Gibbs RA; Bercaw-Pratt JL; Rao SL; Rainusso N; Fisher KE; Lin FY; Plon SE; Parsons DW; Roy A
Cancer Genet; 2022 Apr; 262-263():53-56. PubMed ID: 35026696
[No Abstract] [Full Text] [Related]
15. DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.
Goulvent T; Ray-Coquard I; Borel S; Haddad V; Devouassoux-Shisheboran M; Vacher-Lavenu MC; Pujade-Laurraine E; Savina A; Maillet D; Gillet G; Treilleux I; Rimokh R
Histopathology; 2016 Jan; 68(2):279-85. PubMed ID: 26033501
[TBL] [Abstract][Full Text] [Related]
16. The co-occurrence of an ovarian Sertoli-Leydig cell tumor with a thyroid carcinoma is highly suggestive of a DICER1 syndrome.
Durieux E; Descotes F; Mauduit C; Decaussin M; Guyetant S; Devouassoux-Shisheboran M
Virchows Arch; 2016 May; 468(5):631-6. PubMed ID: 26983701
[TBL] [Abstract][Full Text] [Related]
17. DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors.
Karnezis AN; Wang Y; Keul J; Tessier-Cloutier B; Magrill J; Kommoss S; Senz J; Yang W; Proctor L; Schmidt D; Clement PB; Gilks CB; Huntsman DG; Kommoss F
Am J Surg Pathol; 2019 May; 43(5):628-638. PubMed ID: 30986800
[TBL] [Abstract][Full Text] [Related]
18. Ovarian sex cord-stromal tumors in patients with probable or confirmed germline DICER1 mutations.
Oost EE; Charles A; Choong CS; Leung YC; Salfinger S; Sonnendecker H; Tan J; Townshend S; Witkowski L; Foulkes WD; Stewart CJ
Int J Gynecol Pathol; 2015 May; 34(3):266-74. PubMed ID: 25844550
[TBL] [Abstract][Full Text] [Related]
19. Moderately differentiated Sertoli-Leydig cell tumour: a hormone-secreting neoplasm associated with DICER1 syndrome.
Khan S; Hodgson A
Int J Gynecol Cancer; 2023 Dec; 33(12):1981-1982. PubMed ID: 37543372
[No Abstract] [Full Text] [Related]
20. DICER1 exons 25 and 26 mutations are rare in common human tumours besides Sertoli-Leydig cell tumour.
Kim MS; Lee SH; Yoo NJ; Lee SH
Histopathology; 2013 Sep; 63(3):436-8. PubMed ID: 23763383
[No Abstract] [Full Text] [Related]
[Next] [New Search]
